Centre for Molecular Medicine Norway (NCMM)
The Centre for Molecular Medicine Norway (NCMM), (www.ncmm.uio.no) was established in 2007 as a national partnership institution with the European Molecular Biology Laboratory (www.embl.org) together with similar centres in Sweden and Finland under the Nordic EMBL Partnership. NCMM is inaugurated as joint venture between the University of Oslo as host, the Research Council of Norway and Health Region South East.
The overall objective of NCMM is to facilitate translation of discoveries in basic medical research into clinical practice. NCMM will focus particularly on disease mechanisms where Norway has clear strengths and will investigate mechanisms of non-communicable diseases such as cancer, cardiovascular and CNS-related disease and immune disorders. The Nordic EMBL partnership aims to exploit emerging technologies as part of a process towards molecular and personalized medicine and will capitalize on synergies within the Nordic region.